NCT01736657View on ClinicalTrials.gov

Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Sickle Cell Disease
Interventions
DEVICE

Red blood cell exchange in sickle cell

One Red Blood Cell Exchange using Spectra Optia Apheresis System per enrolled patient

Trial Locations (5)

21205

Johns Hopkins Medical, Baltimore

35233

Children's of Alabama, Birmingham

40202

Kosair Children's Hospital, Louisville

80045

University of Colorado at Denver, Aurora

94609

Children's Hospital and Research Center at Oakland, Oakland

All Listed Sponsors
lead

Terumo BCT

INDUSTRY

NCT01736657 - Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients | Biotech Hunter | Biotech Hunter